psrwe-package: PS-Integrated Methods for Incorporating RWE in Clinical...

In psrwe: PS-Integrated Methods for Incorporating RWE in Clinical Studies

PS-Integrated Methods for Incorporating RWE in Clinical Studies

Description

This package provide R functions for conducting clinical studies with real-world evidence (RWE) incorporated in the study design and analysis.

PS-integrated power prior

We extend the Bayesian power prior approach for a single-arm study (the current study) to leverage external real-world data (RWD). We use propensity score methodology to pre-select a subset of real-world data containing patients that are similar to those in the current study in terms of covariates, and to stratify the selected patients together with those in the current study into more homogeneous strata. The power prior approach is then applied in each stratum to obtain stratum-specific posterior distributions, which are combined to complete the Bayesian inference for the parameters of interest.

PS-integrated composite likelihood

A propensity score-integrated composite likelihood (PSCL) approach is developed for cases in which the control arm of a two-arm randomized controlled trial (RCT) (treated vs. control) is augmented with patients from real-world data (RWD) containing both clinical outcomes and covariates at the patient-level. The PSCL approach first estimates the propensity score for every patient as the probability of the patient being in the RCT rather than the RWD, and then stratifies all patients into strata based on the estimated propensity scores. Within each propensity score stratum, a composite likelihood function is specified and utilized to down-weight the information contributed by the RWD source. Estimates of the stratum-specific parameters are obtained by maximizing the composite likelihood function. These stratum-specific estimates are then combined to obtain an overall population-level estimate of the parameter of interest.

References

Chen WC, Wang C, Li H, Lu N, Tiwari R, Xu Y, Yue LQ. Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data. *Journal of Biopharmaceutical Statistics*. 2020; 30(3):508-520.

Wang C, Lu N, Chen WC, Li H, Tiwari R, Xu Y, Yue LQ. Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies. *Journal of Biopharmaceutical Statistics*. 2020; 30(3):495-507.

Wang C, Li H, Chen WC, Lu N, Tiwari R, Xu Y, Yue LQ. Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies. *Journal of Biopharmaceutical Statistics*. 2019; 29(5):731-748.

psrwe documentation built on March 18, 2022, 5:33 p.m.